New ECLIPSE study validates the accuracy of Shield.  See the data

05/02/2022

Guardant Health Announces Colorectal Cancer Blood Test for Average-Risk Adults

Today, precision oncology company Guardant Health announced the availability of Shield, a blood-based test for the detection of early-stage colorectal cancer (CRC)….

Back to Blog Listing

Sign up to receive the latest updates on ShieldTM

By clicking the button above, you agree to receive periodic product-related updates via email from Guardant Health.